Ads
related to: novartis stock price today
Search results
Novartis AG's (VTX:NOVN) Stock Is Going Strong: Have Financials A Role To Play?
Simply Wall St. via Yahoo Finance· 5 months agoMost readers would already be aware that Novartis' (VTX:NOVN) stock increased significantly by 5.3%...
Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
Investor's Business Daily· 2 months agoBiotech stocks heated up Thursday, driven by a spate of deals, as Novartis scooped up a licensing...
Novartis (NVS) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo Finance· 3 months agoNovartis (NVS) closed the latest trading day at $99.77, indicating a -1.58% change from the previous...
Novartis (NVS) Stock Moves -0.2%: What You Should Know
Zacks via Yahoo Finance· 9 months agoNovartis (NVS) closed at $97.89 in the latest trading session, marking a -0.2% move from the prior...
Novartis (NVS) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance· 2 months agoIn the latest trading session, Novartis (NVS) closed at $95.79, marking a -1.14% move from the...
Top Stock Reports for Procter & Gamble, Novartis & Mondelez International
Zacks via Yahoo Finance· 6 months agoToday's Research Daily features new research reports on 16 major stocks, including The Procter &...
Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks via Yahoo Finance· 2 months agoNovartis (NVS) closed at $95.88 in the latest trading session, marking a +0.64% move from the prior...
Here's Why Novartis (NVS) Is a Great 'Buy the Bottom' Stock Now
Zacks via Yahoo Finance· 12 months agoAfter losing some value lately, a hammer chart pattern has been formed for Novartis (NVS),...
How Novartis' Laggard Business Was Its Second-Quarter Saving Grace
Investor's Business Daily· 2 years agoSwiss drugmaker Novartis delivered a mixed second-quarter report Tuesday, but Novartis stock popped...
Novartis' (NVS) Shareholders Approve Sandoz Separation
Zacks via Yahoo Finance· 8 months agoNovartis AG NVS announced that its shareholders agreed to the proposed 100% spin-off of its generic...